No abstract available
MeSH terms
-
Aged
-
Antineoplastic Agents / adverse effects*
-
Antineoplastic Agents / therapeutic use
-
Benzamides
-
Blast Crisis / chemically induced
-
Blast Crisis / immunology
-
Blast Crisis / physiopathology
-
Dasatinib
-
Hematopoietic Stem Cell Transplantation
-
Humans
-
Iatrogenic Disease / prevention & control
-
Imatinib Mesylate
-
Immunosuppressive Agents / therapeutic use
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / immunology
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / physiopathology
-
Male
-
Middle Aged
-
Piperazines / pharmacology
-
Piperazines / therapeutic use
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / chemically induced*
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / immunology
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / physiopathology
-
Prednisone / therapeutic use
-
Protein Kinase Inhibitors / adverse effects*
-
Protein Kinase Inhibitors / therapeutic use
-
Pyrimidines / adverse effects*
-
Pyrimidines / pharmacology
-
Pyrimidines / therapeutic use
-
Remission Induction / methods
-
Thiazoles / adverse effects*
-
Thiazoles / therapeutic use
-
Treatment Outcome
Substances
-
Antineoplastic Agents
-
Benzamides
-
Immunosuppressive Agents
-
Piperazines
-
Protein Kinase Inhibitors
-
Pyrimidines
-
Thiazoles
-
Imatinib Mesylate
-
nilotinib
-
Dasatinib
-
Prednisone